Shares of Alexion Pharmaceuticals were soaring on Thursday and Friday after the company along with Amgen announced an agreement in a patent battle over blockbuster rare-disease drug Soliris. In a Wednesday filing, a judge with the Patent Trial and Appeal Board said that Alexion and Amgen which brought the suit, had asked to postpone the … Continue reading “Amgen and Alexion Pharmaceuticals Reach Agreement in Patent Battle”
Biotech & Pharma
Moderna Shares Soar on Positive Results on Early Stage Coronavirus Vaccine Trial
Shares of Moderna were surging in Monday's trading session after the company revealed positive data…
Pfizer is Planning to Test Coronavirus Vaccine on Thousands of People
With the coronavirus pandemic still going and with no end in sight, drug makers are…
Crispr Therapeutics Explodes 15% After New Blood Disease Drug Gets Fast-Track
Shares of Crispr Therapeutics were on the rise since Monday, shooting up almost 15% after…
Mylan CEO Says Company Had “Minimal Disruption” During Coronavirus Pandemic
According to Mylan CEO Heather Bresch, the company's global supply chain has helped it experience…
FDA is in Discussions with Gilead to Make Remdesivir Available As Quickly as Possible
At the rate of how many are being infected with coronavirus and how many are…
Biogen Tumbles After Delay of Alzheimer’s Treatment Submission
Shares of biotech giant Biogen were falling on Wednesday after the company said it would…
Gilead Sciences Gets a Downgrade from BMO Capital and Wells Fargo
Shares of Gilead Sciences were downgraded on Monday by not one but two firms, BMO…
Abbott Gets Approval for a Coronavirus Test that Can Get Results in 5 Minutes
One of the biggest issues with the coronavirus pandemic is that there are not enough…
A Japanese Flu Drug May Be Able to Treat Coronavirus
According to an NHK report, there is a Japanese flu drug that could be effective…
Revolution Medicines Inc. Explodes on First Day of Trading
Clinical stage oncology company Revolution Medicines, Inc. made its debut in the stock market on…
Aimmune Shares Explode on Peanut Allergy Treatment Approval from FDA
Aimmune Therapeutics saw its shares flying on Monday after the company gained Food and Drug…
Novavax Initiates Development of Vaccine for Wuhan Coronavirus
Novavax, a clinical-stage vaccine company headquartered in Gaithersburg, Maryland, saw its shares explode 60% in…
Clovis Oncology Shares Soar on Positive FDA News
Shares of biopharmaceutical company Clovis Oncology were soaring on Wednesday after the company said the…